Literature DB >> 6303383

Haematological reconstitution following high dose and supralethal chemo-radiotherapy using stored, non-cryopreserved autologous bone marrow.

A K Burnett, P Tansey, C Hills, M J Alcorn, T Sheehan, G A McDonald, S W Banham.   

Abstract

Eighteen patients with small cell carcinoma of the lung received high dose cyclophosphamide (180-200 mg/kg) intensification following five pulses of 'CHOP' chemotherapy (cyclophosphamide 750 mg/m2 i.v., adriamycin 50 mg/m2 i.v., vincristine 1.4 mg/m2 i.v., prednisolone 40 mg orally for 5 d). They received infusions of autologous bone marrow which had been stored at 4 degrees C for 34 h. Pancytopenia was predictable in onset and its duration acceptable. Recovery of neutrophils to greater than 1.0 x 10(9)/l was achieved in 17.5 +/-0.9 d (mean +/- SEM) and platelets to greater than 100 x 10(9)/l in 17.5 +/- 0.8 d. Four patients with acute myeloid leukaemia in complete remission received intensification with the supralethal combination of cyclophosphamide and total body irradiation followed by infusion of autologous marrow which had been stored at 4 degrees C for 54 h. Haematological reconstitution in these patients was acceptable but slower (greater than 1.0 x 10(9)/l neutrophils between days 26 and 40; greater than 20 x 10(9)/l platelets between days 23 and 77). Except in one case, normal peripheral counts were attained in all patients. It is concluded that bone marrow stored at 4 degrees C for up to 54 h is a simple and practical source of viable stem cells which have the capacity for acceptable haematological reconstitution.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6303383     DOI: 10.1111/j.1365-2141.1983.tb02100.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  ACP Broadsheet No 134: December 1992. How to harvest bone marrow for transplantation.

Authors:  R Jones; A K Burnett
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

2.  Hematopoietic reconstitution after high-dose chemotherapy and autologous nonfrozen bone marrow rescue.

Authors:  H Köppler; K H Pflüger; K Havemann
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

3.  Storage of noncryopreserved periphered blood stem cells for transplantation.

Authors:  G Hechler; R Weide; J Heymanns; H Köppler; K Havemann
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

4.  Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: a report from the Spanish GEL/TAMO Cooperative Group.

Authors:  J Sierra; E Conde; A Iriondo; S Brunet; J Marín; J Pérez de Oteiza; D Caballero; F Martínez; A León; J García-Conde
Journal:  Ann Hematol       Date:  1993-09       Impact factor: 3.673

5.  High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung.

Authors:  D Cunningham; S W Banham; A H Hutcheon; A Dorward; S Ahmedzai; P Tansey; M Soukop; R D Stevenson; B R Stack; S B Kaye
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides.

Authors:  A A Fauser; E Lang; G Dölken; K J Bross; J Schmid; F Sörgel
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553

7.  Storage of hemopoietic stem cells.

Authors:  Derwood Pamphilon; Aleksandar Mijovic
Journal:  Asian J Transfus Sci       Date:  2007-07

8.  Circulating hematopoietic progenitors in patients with primary lung cancer.

Authors:  E Shimizu; J N Mukai; Y Takaue; T Ogura
Journal:  Jpn J Cancer Res       Date:  1990-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.